Posted by Michael Wonder on 08 Jul 2020
ICER reschedules cystic fibrosis public meeting for 27 August 2020
8 July 2020 - Registration is now open.
The Institute for Clinical and Economic Review announced today that the public meeting to discuss the comparative clinical effectiveness and value of treatments for cystic fibrosis is rescheduled to 27 August 2020, and will be held virtually.
This public meeting was previously postponed due to the COVID-19 pandemic. The Evidence Report will be subject to deliberation during this public meeting of the California Technology Assessment Forum, one of ICER’s three independent evidence appraisal committees.
